Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% ...

Neogen recently reported that it is contending with falling sales, shrinking returns on capital and EBITDA losses, raising concerns about its operational and financing flexibility. This combination of ...

What a fantastic six months it’s been for Neogen. Shares of the company have skyrocketed 53.5%, hitting $9.46. This was partly thanks to its solid quarterly results, and the run-up might have ...

Neogen gains attention after executive equity grants, highlighting operational challenges, integration focus, and evolving ...

What Happened? A number of stocks fell in the afternoon session after the renewed Iran-UAE incident reignited concerns about ...

Neogen (NASDAQ:NEOG) is set to give its latest quarterly earnings report on Thursday, 2024-10-10. Here's what investors need to know before the announcement. Analysts estimate that Neogen will report ...

The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly ...

Life sciences company Neogen (NASDAQ:NEOG) reported Q3 CY2025 results , but sales fell by 3.6% year on year to $209.2 million. The company’s full-year revenue guidance of $830 million at the midpoint ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. “Food producers and contract labs around the world have long trusted the ...